| Characteristic | Savings in million Canadian dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
March 2015
Region
Canada
Survey time period
FY 2012/2013
Supplementary notes
* Total results are for top 5 entry drugs and only for select public drug plans included in this report.
Citation formats









